Abdul Mannan on Finding the Right Balance – The Blood Thinner Dilemma
Abdul Mannan, Consultant Haematologist at Betsi Cadwaladr University Health Board, posted on LinkedIn:
”Stopping blood thinners after a clot is tricky. You might stop too soon and get another clot. Or you might stay on them too long and bleed.
We used to rely on fancy scores and tests. Now guidelines say don’t bother with most of them. Just talk to your patient.
If the clot had no clear cause, you probably need longer treatment. If it happened after surgery, you can stop sooner.
Cancer patients stay on treatment whilst the cancer is active. Simple as that.
Three months treats the clot. After that, you’re preventing the next one. That’s when the hard choices start.
Some tools help predict risk. But ASH says use them only if they’ll actually change your plan. Otherwise, skip them.
Lower doses work for prevention after the first months. Balance is everything.”
Stay updated with Hemostasis Today.
-
Sep 19, 2026, 01:53Thomas Dayspring: Understanding Genome and Lipid Interactions in Lipidology
-
Sep 19, 2026, 01:47Abdurrahman Tufan: Combination Targeted Therapy in Refractory Systemic Autoinflammatory Diseases
-
Sep 19, 2026, 01:44Patrick James Lynch: Mother of a Thousand Sons Premieres at BDC 2026
-
Sep 19, 2026, 01:41Genetic Fate Mapping Reveals Endothelial Cells During Venous Thrombus Resolution – RPTH Journal
-
Sep 19, 2026, 01:39Mostafa Hammam: Three Different Platelet Defects – One Common Symptom
-
Sep 19, 2026, 01:38Jeff Sternlicht: A Heart Attack Should Not Be the Starting Line
-
Sep 19, 2026, 01:28Luis Oliverio Ambriz Garcia: Key Points From the ASH 2026 Guidelines on Iron Deficiency
-
Sep 19, 2026, 01:27Farjah Algahtani: A New Era in the Treatment of Transfusion-Dependent Thalassaemia
-
Sep 19, 2026, 01:24Aravind Palraj: 2025 EULAR Behçet’s Syndrome Update – 5 Practical Take-Home Points